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Abstract
We have developed a novel structure-based approach to search for Complimentary Ligands Based
on Receptor Information (CoLiBRI). CoLiBRI is based on the representation of both receptor binding
sites and their respective ligands in a space of universal chemical descriptors. The binding site atoms
involved in the interaction with ligands are identified by the means of computational geometry
technique known as Delaunay tessellation as applied to x-ray characterized ligand-receptor
complexes. TAE/RECON1 multiple chemical descriptors are calculated independently for each
ligand as well as for its active site atoms. The representation of both ligands and active sites using
chemical descriptors allows the application of well-known chemometric techniques in order to
correlate chemical similarities between active sites and their respective ligands. From these
calculations, we have established a protocol to map patterns of nearest neighbor active site vectors
in a multidimensional TAE/RECON space onto those of their complementary ligands, and vice versa.
This protocol affords the prediction of a virtual complementary ligand vector in the ligand chemical
space from the position of a known active site vector. This prediction is followed by chemical
similarity calculations between this virtual ligand vector and those calculated for molecules in a
chemical database to identify real compounds most similar to the virtual ligand. Consequently, the
knowledge of the receptor active site structure affords straightforward and efficient identification of
its complementary ligands in large databases of chemical compounds using rapid chemical similarity
searches. Conversely, starting from the ligand chemical structure, one may identify possible
complementary receptor cavities as well. We have applied the CoLiBRI approach to a dataset of 800
x-ray characterized ligand receptor complexes in the PDBbind database2. Using a k nearest neighbor
(kNN) pattern recognition approach and variable selection, we have shown that knowledge of the
active site structure affords identification of its complimentary ligand among the top 1% of a large
chemical database in over 90% of all test active sites when a binding site of the same protein family
was present in the training set. In the case where test receptors are highly dissimilar and not present
among the receptor families in the training set, the prediction accuracy is decreased; however
CoLiBRI was still able to quickly eliminate 75% of the chemical database as improbable ligands.
The CoLiBRI approach provides an efficient prescreening tool for large chemical databases prior to
traditional, yet much more computationally intensive, three-dimensional docking approaches.
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Computer Aided Drug Design (CADD) is frequently identified with two concurrent
approaches: structure-based and ligand-based modeling. Structure-based methodologies
employ either an experimentally (X-ray or NMR) determined or predicted three-dimensional
structure of a target protein. This structure is used to scan available chemical databases or
virtual combinatorial libraries for the identification of potential lead compounds, which are
characterized by stereochemical complementarity to the active site and have a high predicted
binding constant. The binding constant estimate requires a fast and accurate scoring function.
Several successful studies have been reported in the literature using popular docking methods
such as DOCK3–6 and AutoDock7;8. Typically, these approaches are capable of identifying a
small number of compounds that can fit comfortably into the active site. Despite these success
stories, accurate prediction of binding constants still represents a formidable task and is a focus
of many ongoing investigations9.
Theoretically, the most accurate estimate of the free energy of binding can be obtained using
energy based methods. These methods typically employ force fields originally developed for
the refinement of experimentally-determined molecular structures or for molecular dynamics
simulations. Examples include free energy perturbation (FEP)10;11 or Linear Interaction
Energy (LIE) approaches12–14, which require significant computational resources. Application
of continuum solvation models, instead of explicit solvent, can significantly reduce the cost of
these calculations15. However, the computational cost of such methods is still too demanding
to afford calculations in a high-throughput fashion, and therefore these calculations can only
be practical if applied to either relatively simple systems or small sets of compounds with
similar binding modes.
Ligand-based approaches rely on a series of ligands with known binding affinities to build
correlations between ligand chemical structure and target properties of interest, such as binding
constants or specific biological activities [see 16 for a recent review]. The ligand structures are
typically represented by multiple chemical descriptors17, and statistical data modeling
techniques are used to establish quantitative correlations between descriptors and binding
affinities. Chemical descriptors and various chemical similarity measures (e.g., Euclidean
distances between compounds in multidimensional descriptor space) are at the core of
chemometric approaches to the analysis of molecular databases18. Such approaches afford
rapid chemical similarity calculations and are widely used in database mining or rational library
design to discover molecules similar to available compounds that are likely to have similar
biological activity19. Chemical similarity searches are much more computationally efficient
than structure based virtual screening. However, they are more likely to identify false positives
that are too bulky or simply not stereochemically complementary to the actual binding site
because the binding site information is not typically used as part of the query. Furthermore,
chemometric approaches typically identify compounds that are highly similar to the training
set compounds, making it difficult to identify novel ligands of a different structural class.
In this paper, we discuss a novel computational drug discovery strategy that combines the
strengths of both structure-based and ligand-based approaches while attempting to surpass
their individual shortcomings. To this end, we sought a representation that would allow us to
characterize both receptor active sites and their corresponding ligands in the same universal,
multidimensional, chemical descriptor space. We reasoned that mapping of both binding
pockets and corresponding ligands onto the same multidimensional chemistry space would
preserve the complementarity relationships between binding sites and their respective ligands.
Thus, we expected that similar binding sites (where similarity is described quantitatively using
one of the conventional metrics, such as Manhattan distance in multidimensional descriptor
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space) would correspond to similar ligands. This would imply that the relative location of a
novel binding site in this chemistry space with respect to other binding sites could be used to
predict the location of the ligand(s) complementary to this site in the ligand chemistry space.
This virtual ligand(s) could then be used as a query in chemical similarity searches to identify
putative ligands of the same receptor in available chemical databases.
To implement this strategy, we have used molecular descriptors based on Transferable Atom
Equivalents (TAE) developed by Breneman and co-workers1;20;21. The major advantage of
these descriptors over other descriptor types (discussed briefly in the next section) is that they
are derived from the electronic and shape properties of isolated atoms or chemical groups. The
additivity principle is used to calculate molecular descriptors by summing up the individual
descriptor type values for all atoms in the molecule, using the RECON method. In the case of
ligands, this leads to the generation of molecular descriptors, similar to other approaches. The
same additivity principle can also be used to derive pseudo-molecular descriptors for any group
of atoms, e.g., active site fragments, making the TAE descriptors exceptionally well suited for
our approach.
In this paper, we report on the application of this chemometric structure based drug discovery
strategy, termed CoLiBRI (identification of Complimentary Ligand Based on Receptor
Information), to a training set of 800 diverse ligand-receptor complexes comprising the
PDBBind dataset2. We show that the knowledge of the receptor active site affords the highly
computationally efficient and accurate identification of its respective ligand(s) within a large
compound database. The success of this pilot study indicates that the CoLiBRI method can
become an efficient alternative to traditional structure based drug discovery approaches or used




Coordinates for 800 chemically and functionally diverse ligand-receptor complexes were
obtained from the PDBbind Database2 (PDB entry codes for these proteins are listed in the
supplementary information). SYBYL v6.822 was used to pre-process the raw macromolecular
structures, including elimination of the crystallographic water molecules, removal of salts, and
addition of hydrogen atoms.
Chemical descriptors
Several important considerations went into finding the most capable descriptors in the context
of our studies. There are two major classes of traditional chemical descriptors that are derived
from either two-dimensional chemical graphs (e.g., molecular connectivity indices, charge
descriptors, and others 23–29), or from three-dimensional molecular models using relative
atomic positions in addition to atom properties. A major benefit of 2D compared to 3D
chemometric methods is that the former neither requires a conformational search nor structural
alignment of molecules. Accordingly, 2D methods are more easily automated and adapted to
the task of database searching, or virtual screening30. In fact, 2D descriptors have been shown
to be superior to 3D descriptors in database mining31. However, most 2D chemical descriptors
are typically calculated from only complete molecular graphs. Consequently, they can not be
used to characterize active sites that are composed of fragments or individual atoms of amino
acid residues that are involved in specific contacts with ligands. A notable exception is the
TAE descriptors, as discussed in the Introduction.
The TAE/RECON method that was developed by Breneman and co-workers is based on the
Bader's quantum theory of atoms in molecules (AIM). The TAE method of molecular electron
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density reconstruction utilizes a library of integrated atomic “basins”, as defined by the AIM
theory, to rapidly reconstruct representations of molecular electron density distributions and
van der Waals electronic surface properties. RECON is capable of rapidly generating 6-31+G*
level electron densities and electronic properties of large molecules, proteins or molecular
databases, using TAE reconstruction. A library of atomic charge density fragments has been
assembled in a form that allows for the rapid retrieval of the fragments, followed by rapid
molecular assembly. Additional details of the method are described elsewhere 1;20;21.
Calculation of TAE/RECON descriptors for ligands and their binding sites
The calculation of TAE/RECON descriptors for the ligands (extracted from their protein
complexes) was straightforward. However, similar calculations for the binding sites first
required the identification of individual atoms or amino acid fragments involved in specific
ligand-receptor interactions. To this end, we have utilized a computational geometry technique
known as Delaunay tessellation to isolate the protein atoms that make contacts with bound
ligands. Applied to a collection of randomly distributed points, Delaunay tessellation partitions
the space occupied by these points into and aggregate of space filling, irregular triangles (in
2D) or tetrahedra (in 3D) with the original points as vertices. Thus, this approach effectively
identifies all narest neighbor triplets (or quadruplets) of vertices. An example of Delaunay
tessellation in two dimensions is illustrated in Figure 1.
Protein-ligand complexes are represented by the coordinates of their heavy atoms (i.e., in a
hydrogen-depleted form). Delaunay tessellation of this representation uniquely defines all sets
of nearest neighbor atom quadruplets, including three types of interfacial quadruplets: three
receptor atoms and one ligand atom; two receptor and two ligand atoms; and one receptor and
three ligand atoms. Thus, Delaunay tessellation affords an easy way of detecting all receptor
atoms that are nearest neighbors of the ligand atoms, which are specified as the active site. The
RECON/TAE method is then used as described above to generate a set of descriptors for pseudo
molecule constructed from the active site atoms. An example of tessellated ligand-receptor
complex is shown in Figure 2.
The descriptors generated with TAE/RECON were range scaled prior to distance calculations
(eq. 1).
(1)
We chose to scale descriptors so that their absolute ranges after scaling are the same. Had we
used the real values, the value of the absolute distance between receptors or ligands would be
biased by the descriptors that cover the largest ranges.
CoLiBRI algorithm
Using the TAE/RECON method, multiple descriptors were generated for both the receptor
binding sites and their corresponding ligands so that each chemical entity is represented as a
vector in a multidimensional TAE/RECON chemical space. Each dimension of this space
corresponds to specific structural features of the ligands and active sites, but not every feature
may be important for determining ligand-receptor complementarity. In order to select the
subset of descriptors that best reflect the complementarity between receptors and their
respective ligands, we have employed a Leave-One-Out (LOO) approach with variable
selection. For each predefined number of variables, (nVar) we used stochastic sampling of the
descriptors space and simulated annealing to optimize: (i) a selection of variables from the
original pool of all molecular descriptors that are used to calculate relative similarities between
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receptors and their respective ligands (i.e., Euclidean distances in nVar-dimensional descriptor
space), and (ii) the number of nearest neighbors (k) for each binding site in the receptor
chemistry space used to estimate the position of the virtual complementary ligand in the ligand
chemistry space. The overall flow chart of the CoLiBRI method is shown in Figure 3 and
involves the following steps.
(1) Select a subset of nVar descriptors randomly (nVar is a number between 1 and the total
number of available descriptors). nVar is usually set to different values in several different
runs. (2) Perform internal evaluation of this selection by a standard LOO cross-validation
procedure and calculate the predictive mean rank (PMR) for the model as described below. (3)
Repeat the procedure of generating trial correlations and calculate the corresponding PMR
values (steps 1 and 2). The goal is to find the best topological requirements that minimize the
PMR value of the CoLiBRI model. This optimization process is driven by a generalized
simulated annealing (see below) using PMR as the objective function.
Cross-validation and the kNN principle applied to complementary prediction
The standard leave-one-out cross-validation procedure has been implemented as follows.
1. Choose a receptor in the training set and select its k nearest neighbors in the TAE/
RECON binding site descriptor space. Identify the ligands of the kNN receptors in
the ligand space and use their coordinates to predict the coordinates of the chosen
receptor’s virtual ligand. The coordinates of the virtual ligand are calculated from
equation 2 for k≥2 (different values of k are explored to find the best model as
described below).
(2)
where XRPredi is the chosen receptor i, Xppi is the predicted ligand vector for the
receptor i, XRk is the k nearest receptor, and XL←Rk is the ligand of the k nearest
neighbor receptor. For the case where KBest = 1, then Xppj is simply the position of
the nearest receptor’s ligand in the ligand space, XL←R1.
2. Rank known ligands based on their chemical similarity to the virtual ligand. The
similarities are evaluated as Euclidean distances (eq. 3) using only the subset of
descriptors that correspond to the current nVar selection.
(3)
3. Repeat steps 1 and 2 until every receptor in the training set has been eliminated once,
and the receptor’s virtual ligand and the rank order of all compounds are predicted.
4. Calculate the PMR for the model using eq. 4, where NLR is the number of ligand-
receptor complexes in the training set, Nvar is the number of descriptors used to build
the correlation, Xjd and Xid are the dth selected descriptor for ligands j and i, and
Xppi d is the dth descriptor of the predicted ligand point.
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5. Repeat steps 1 through 4 for k = 3, 4, 5, etc. Formally, the upper limit of k is the total
number of ligand-receptor pairs in the data set minus one; however, the best value
has been found empirically to lie between two and five. The k value that leads to the
lowest PMR value is chosen as optimal.
Simulated annealing based optimization for variable selection
The concept of simulated annealing (SA) is to simulate a physical process called annealing, in
which a system is heated to a high temperature and then is gradually lowered to a preset
temperature value. During this process, the system samples possible configurations according
to the Boltzmann distribution. At equilibrium, low energy states will be mostly populated. The
first implementation of the SA procedure was described by32 followed by the development of
a more generalized mathematical optimization protocol. The implementation of SA in our
studies is as follows. (1) Generate a trial solution to the underlying optimization problem. For
example, a CoLiBRI model is built based on a random selection of nVar descriptors. (2)
Calculate the value of the fitness function, which characterizes the quality of the trial solution
to the underlying problem, i.e., the inverse of the PMR value for a model built using only the
selected nVar descriptors (PMRCurrent). (3) Perturb the trial solution to obtain a new solution;
i.e., change a fraction of the currently used descriptors to other randomly selected descriptors
and build a new CoLiBRI model for the new trial set of nVar descriptors. (4) Calculate the new
fitness function value for the trial solution as the inverse of the new PMR value (PMRNew).
(5) Apply the optimization criteria: if PMRCurrent < PMRNew the new solution is accepted and
used to replace the current trial solution; if PMRCurrent > PMRNew, the new solution is accepted
only if the following Metropolis criterion is satisfied (eq. 5).
(5)
where rnd is a random number uniformly distributed between 0 and 1 and T is a parameter
analogous to the temperature in Boltzmann distribution law. (6) Steps 3–5 are repeated until
the termination condition is satisfied. The temperature lowering scheme and the termination
condition used in this work have been adapted from33 as implemented by34. Thus, every time
a new solution is accepted or when a preset number of successive trial solutions (100 steps) do
not lead to a better result, the temperature is lowered by a preset value, usually by 10% (the
default initial temperature is 100). The calculations are terminated when either the current
temperature of the simulations is lowered to the value of T=10−6 or the ratio between the current
temperature and the temperature corresponding to the best solution found is equal to 10−5. In
summary, the CoLiBRI generates both an optimum k value and an optimal subset of nVar
descriptors, which together produce a model with the best internally predictive power, in terms
of PMR. This model can be used to identify correlations between a receptor active site and its
ligand(s) such that a predicted point can be found for any receptor; and vice-versa, a predicted
receptor point can be found for any ligand.
Oloff et al. Page 6














Training and Test Set Selection—The dataset of 800 ligand-receptor complexes
characterized by TAE/RECON descriptors was divided into the training (data used for model
building) and test (data used for model validation) sets using the sphere exclusion method
implemented in this laboratory35. Only binding site descriptors were used for these
calculations. The purpose for this division was to generate a subset of ligands that did not bind
any of the receptors in the training set. For the prediction of test set receptor ligands, the entire
database of ligands was used. For additional validation, the World Drug Index (WDI) database
was added to the list of available test set ligands and CoLiBRI models attempted to identify
known ligands from the entire database.
Data Shuffling—To ensure that the models used to predict a test set were not based on chance
correlations, the training set ligand-receptor associations were randomly shuffled. This data
was then used to build CoLiBRI models, which were used for the test set prediction. If no
significant model could be built for this randomized dataset, it would suggest that the models
built using the correct data accurately ligand-receptor complementarity in high-dimensional
descriptor space.
RESULTS
Development and validation of training set models
A diverse training set of 670 receptor binding pockets was selected using a Sphere Exclusion
Algorithm36, as described above and used by CoLiBRI to build models with the lowest PMR
(Eq. 4). The remaining 130 receptors were used as a test set to evaluate the ability of the
optimized model(s) to identify the correct ligand of each test receptor out of the original 800
ligands.
Previous studies from our group in the area of Quantitative Structure Activity Relationship
(QSAR) indicated that the most reliable predictions of the test set data are obtained by using
the consensus prediction approach37. In this approach, multiple variable selection models are
built for the training set and used for the prediction of the test set ligands concurrently. To
accomplish a consensus prediction, each model ranked all compounds in our ligand database
based on the distance of each ligand to a test receptor’s virtual complementary ligand. We then
re-ranked the ligands based on those that were most similar to the virtual ligand across multiple
models. These studies have shown that the inclusion of variable selection improved the mean
rank of the test set from 37 to 24 out of 800. Furthermore, by using 100 models for consensus
prediction, the mean rank of the test set was improved from 24 to 18.1 out of 800, as shown
in Figure 4. This increased the CPU time required to predict the test set by more than two orders
of magnitude. Despite the increased CPU time, the calculations were still completed within 15
minutes. Since variable selection and consensus modeling vastly improved test set prediction,
these methods were used in all subsequent model developments.
Application of CoLiBRI models to screening the WDI database
To simulate the use of CoLiBRI for screening large chemical databases, we added the 800
training set ligands to the WDI dataset38, which contains ca. 54,000 drugs and drug candidates.
Training set CoLiBRI models were used in a consensus manner to predict the correct ligands
for each of the 130 test receptors from of the entire combined database. The results illustrated
that even when searching a large compound database, CoLiBRI is, on average, able to rank
known ligands for a test receptor to within the top 310 ligands out of ca. 54,000, which translates
to the top 1% of all compounds, as shown in Figure 5. The entire screening calculation for 130
test receptors took roughly four hours on a 2.4 GHz Pentium 4 machine. Figure 5 illustrates
that most of the ligands were correctly identified within the top 12 ranked compounds; however
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there were two distant outliers that made the average rank much higher. These two outliers
(PDB codes 1BM7 and 1G4J) did not contain a receptor-ligand complex from the same family
as those in the training set, which could possibly explain the inaccuracy of the predictions. The
ligands extracted from 1BM7 and 1G4J, flufenamic acid and 4-(Aminosulfonyl)-N-[(2,3,4,5,6-
Pentafluorophenyl)methyl]-Benzamide, respectively, also do not appear to be very similar to
ligands found within the training dataset. This additional dissimilarity may have also played a
role in their poor prediction. As discussed in a later section, CoLiBRI appears to perform best
when a receptor of the same family as the test set receptor is present in the training set.
Otherwise, CoLiBRI is best used as a quick, rough filtering tool that can be used prior to the
application of alternative less computationally efficient but perhaps more robust screening
methodologies.
Identification of binding sites based on ligand information
As mentioned above, the CoLiBRI approach could be used to identify ligands based on the
binding site descriptors, as well as predict binding sites for the ligands. The latter application
uses the same formalism (Eq. 2–4), except that ligand coordinates are first mapped onto the
binding site chemistry space, and then the virtual binding site is used as a query in chemical
similarity calculations. We have tested CoLiBRI’s ability to identify the correct binding
pockets for the same series of 130 test ligands for all 800 pockets. On average, CoLiBRI was
able to successfully rank the correct binding pocket to be in the top 20 out of 800, or within
the top 2.5%, as shown in Figure 6. As one can see from the graph, most of the predictions
actually identified the correct binding pocket within the top 2 or 3 receptors. After careful
analysis of the outliers, we discovered that they primarily fell within two classes: either there
were multiple receptors of the same family in the dataset that a test ligand is known to bind
with, and the correct binding site was ranked almost randomly within that top ranked family,
or there were only one or no receptors of the same family in the training set.
Identification of ligands for novel receptor families
As the most rigorous test for CoLiBRI, we explored its ability to predict ligands for receptors
that did not have homologous receptor structures in the training set. To this end, we selected
a test set of 22 ligand-receptor complexes that consists of receptors from three receptor families:
7 complexes from the peptidase M10A family, 7 complexes from the SRC-Tyrosine kinase
family, and 8 complexes from the peptidase S1 family. We then used CoLiBRI to identify the
correct ligands from the WDI for each of the test receptors. The results shown in Figure 7
demonstrate that the accuracy of CoLiBRI under this difficult test has decreased significantly;
we were only capable of identifying the correct ligand within the top 25% of the database on
average, as opposed to the results reported when test receptors were from the same family
(Figure 5). This relative ineffectiveness of CoLiBRI under this test could still be acceptable
when one needs to quickly screen a large, multimillion-compound library (25% accuracy for
correct single hit identification is equivalent to the elimination of 75% of all compounds that
are unlikely to be hits). These observations imply that the three test families are significantly
different from the protein-ligand complexes in the training set so that the training set models
are inapplicable to these test set proteins. In future studies, we shall consider introducing the
model applicability domain for the CoLiBRI models, similar to our QSAR studies 35;39, to
serve as a warning that the predictions may be inaccurate due to high dissimilarities between
complexes known in the training set and test binding pockets or ligands.
CPU requirements of CoLiBRI for efficient screening of large databases
The time required for CoLiBRI to screen the WDI with 100 CoLiBRI models for a single
receptor took less than 2 minutes on a 2.4GHz Pentium 4 Desktop, as shown in Figure 8. These
results illustrate that CoLiBRI may be successfully used as an efficient database filtering tool
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prior to more thorough and computationally intensive docking studies. The reason for the
abrupt change in slope is due to a user-specified limit on the number of potential hits that are
presented as output. For this computational speed assessment test, a limit was set to 5000 ranked
ligands presented as output. Thus, CoLiBRI first ranks the first 5000 compounds (or a user-
defined number) in the database using all models and then sequentially updates this sorted list
as it searches the remainder of the compound database for additional viable hits.
Validation of CoLiBRI models through random shuffling
In order to validate that the models were based on an inherently true correlation between
properties of a receptor and its respective ligand, the ligands were shuffled such that for any
one receptor, a randomly assigned ligand was used in place of the true ligand for model
building. A test set of 130 receptors were then used to attempt the identification of the correct
binding pockets using the models built on randomly associated ligand-receptor complexes. The
PMRs for actual ligands (Figure 9) appear to be completely random suggesting that the models
built with real data are based on actual complementarity correlations and are not artifacts of
the model building process.
Discussion
The main objective of CoLiBRI is to build chemometric models that reflect complementarity
between a receptor’s active site and its ligand, such that by knowing either the binding site or
the ligand for a given receptor, a researcher could identify its complement from all other
possibilities in a virtual database. In contrast with QSAR approach, which requires a dataset
of known ligands for a particular receptor in order to build models and search for additional
ligands of that receptor, CoLiBRI only requires the structure of the binding pocket. On the
other hand, as compared with traditional 3D docking, CoLiBRI training set models are built
across the entire available collection of diverse ligand receptor complexes as opposed to using
a single receptor of interest for virtual screening. Consequently, CoLiBRI models use
information about all other receptors when making prediction of ligands that bind to a particular
receptor. In addition, CoLiBRI is significantly more computationally efficient that most 3D
docking approaches.
As discussed above (cf Fig. 6), the “inverse” CoLiBRI approach could be also used to identify
potential binding sites for a ligand. Binding to alternative sites is a frequent cause of side effects
of drugs. The ability to identify potential undesirable interactions before a drug is brought to
market is invaluable to the pharmaceutical industry. Foreknowledge of such interactions could
send an otherwise effective compounds back through the lead optimization process before
immense resources were lost in clinical trials. The structure of the ligand could be modified
such that unwanted interactions are removed, while still maintaining its target property, thus
leading to a highly useful drug.
To the best of our knowledge, the studies presented in this report are the first attempt to employ
chemoinformatics approaches to the analysis of ligand-receptor complementarity. They could
be extended in a number of ways. Thus, although this study was done using only TAE
descriptors, in principle the descriptors for the receptor binding pockets and ligands could be
of different types. This avenue worth further investigation: while TAE/RECON method
appears to be unique in its ability to generate pseudo-molecular descriptors for the collection
of active site atoms, a number of other descriptor types are specifically designed for ligands
and may better describe their features. Three dimensional descriptors may also be used for the
active site to preserve distance- and orientation-dependent interactions that may occur between
a receptor and its ligands. Another important concept that we plan to examine in the future is
the implementation of Support Vector Machines40 as an alternative to kNN. The current
approach uses SA variable selection to optimize complementarity. The PMR function could
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easily be made continuous and applicable to Support Vector Theory by replacing k with a
Gaussian weighting scheme and adding a continuous loss function. This could be done such
that all neighbors in the initial starting space would be assigned distance dependent weights,
where dissimilar neighbors would be given a weight of zero and closer neighbors would be
given a weight higher than zero. Ligands or receptor active sites would be penalized based on
their relative distance to their predicted point, which is calculated by orientations in the
complementary space. This would allow us to take advantage of the inherent accuracy and
generalization constraints of Support Vector Machines that may increase the predictive power
of the models. Finally, as briefly mentioned above, a great deal of effort will be placed on
defining adequate applicability domains for CoLiBRI models, which should prevent CoLiBRI
from making unreliable predictions and therefore improve its accuracy.
Conclusions
We have developed a novel, predictive approach termed CoLiBRI to the analysis of ligand-
receptor complementarity based on the representation of both ligands and their receptor active
sites in a universal chemistry space. Unlike traditional docking methodologies that base their
prediction of complimentary ligands using active site information alone, CoLiBRI predicts
virtual ligands of the receptor based on its relative position in multidimensional chemistry
space with respect to other known receptors. This representation affords straightforward and
efficient identification of complementary ligands to a receptor from large databases of chemical
compounds using rapid chemical similarity searches. Conversely, starting from the ligand
chemical structure, one may identify possible complementary receptor cavities as well. This
method is also distinct in that it penalizes the model for predicting an incorrect ligand for a
receptor binding pocket, rather than optimizing the models by trying to correlate ligand binding
to a single receptor. We have demonstrated that the knowledge of the active site structure
affords identification of its complimentary ligands among the top 1% of a chemical database
in 90% of cases, where a complex of the same receptor family was present in the training set.
In the case where test receptors are highly dissimilar and not present among the receptor
families in the training set, the prediction accuracy decreased significantly, however the method
was able to quickly eliminate 75% of the chemical database as improbable ligands. Together,
these results suggest that CoLiBRI can be used efficiently as a prescreening tool for traditional
docking studies in order to identify a relatively small subset of compounds that are likely to
contain actual hits.
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Delaunay tessellations of a collection of random points in 2D.
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Tessellation of ligand-receptor interface identifies all active site atoms that make contacts with
ligand atoms.
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Flowchart of CoLiBRI Method
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Predictive ability of CoLiBRI to identify ligands of 130 test binding pockets out of the original
800 ligands.
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Predictive ability of CoLiBRI to identify ligands of 130 test binding pockets from the WDI
and the original 800 ligands.
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Predictive ability of CoLiBRI to identify receptor binding pockets of 130 test ligands from the
library of 800 binding pockets.
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Predictive ability of CoLiBRI to identify ligands of 22 test binding pockets from the WDI when
there are no receptors of the same family in the training set.
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Time required for 100 CoLiBRI models to screen a single test receptor against various
compound libraries on a P4 machine using a max. limit of 5,000 sorted hits displayed as output.
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Predictive ability of CoLiBRI to identify ligands of 130 test binding pockets when the training
set ligand-receptor associations were shuffled and used for model building.
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